The import of compounds containing a pyrimidine ring or piperazine ring in the structure to Germany is projected to experience a steady decline from 2024 to 2028. Following an initial forecast value of 9.4251 million kilograms in 2024, the import volume is expected to decrease to 8.9905 million kilograms by 2028. This trend represents an average annual reduction rate (CAGR) over the period of approximately 1.2%. As of 2023, the actual import volume was higher than the forecast for 2024, indicating a persistent downward trend in imports.
Future trends to watch for include potential shifts in global supply chains, changes in domestic pharmaceutical manufacturing capabilities, and adjustments in regulatory policies, which could all impact import volumes. Additionally, advancements in synthetic biology and alternative compound synthesis methods may influence future demand and supply dynamics of such chemical compounds in the German market.